229 related articles for article (PubMed ID: 27680756)
1. Influence of Different Peritoneal Dialysis Fluids on the In Vitro Activity of Cefepime, Ciprofloxacin, Ertapenem, Meropenem and Tobramycin Against Escherichia Coli.
Kussmann M; Schuster L; Wrenger S; Pichler P; Reznicek G; Burgmann H; Poeppl W; Zeitlinger M; Wiesholzer M
Perit Dial Int; 2016 11-12; 36(6):662-668. PubMed ID: 27680756
[TBL] [Abstract][Full Text] [Related]
2. Influence of different peritoneal dialysis fluids on the in vitro activity of fosfomycin against Escherichia coli, Staphylococcus aureus, Staphylococcus epidermidis, and Pseudomonas aeruginosa.
Kussmann M; Hauer S; Pichler P; Reznicek G; Burgmann H; Poeppl W; Zeitlinger M; Wiesholzer M
Eur J Clin Microbiol Infect Dis; 2018 Jun; 37(6):1091-1098. PubMed ID: 29546637
[TBL] [Abstract][Full Text] [Related]
3. Stability and Compatibility of Antibiotics in Peritoneal Dialysis Solutions Applied to Automated Peritoneal Dialysis in The Pediatric Population.
Deslandes G; Grégoire M; Bouquié R; Le Marec A; Allard S; Dailly E; Pineau A; Allain-Launay E; Jolliet P; Roussey G; Navas D
Perit Dial Int; 2016 11-12; 36(6):676-679. PubMed ID: 27147292
[TBL] [Abstract][Full Text] [Related]
4. The influence of different peritoneal dialysis fluids on the in vitro activity of ampicillin, daptomycin, and linezolid against Enterococcus faecalis.
Kussmann M; Schuster L; Zeitlinger M; Pichler P; Reznicek G; Wiesholzer M; Burgmann H; Poeppl W
Eur J Clin Microbiol Infect Dis; 2015 Nov; 34(11):2257-63. PubMed ID: 26337433
[TBL] [Abstract][Full Text] [Related]
5. Compatibility of Meropenem with Different Commercial Peritoneal Dialysis Solutions.
Wiesholzer M; Winter A; Kussmann M; Zeitlinger M; Pichler P; Burgmann H; Reznicek G; Poeppl W
Perit Dial Int; 2017 1-2; 37(1):51-55. PubMed ID: 27605684
[TBL] [Abstract][Full Text] [Related]
6. Pharmacodynamic modeling of carbapenems and fluoroquinolones against bacteria that produce extended-spectrum beta-lactamases.
Moczygemba LR; Frei CR; Burgess DS
Clin Ther; 2004 Nov; 26(11):1800-7. PubMed ID: 15639692
[TBL] [Abstract][Full Text] [Related]
7. Bactericidal activities of meropenem and ertapenem against extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a neutropenic mouse thigh model.
DeRyke CA; Banevicius MA; Fan HW; Nicolau DP
Antimicrob Agents Chemother; 2007 Apr; 51(4):1481-6. PubMed ID: 17283197
[TBL] [Abstract][Full Text] [Related]
8. Susceptibilities of Propionibacterium acnes ophthalmic isolates to ertapenem, meropenem, and cefepime.
Shames R; Satti F; Vellozzi EM; Smith MA
J Clin Microbiol; 2006 Nov; 44(11):4227-8. PubMed ID: 16971643
[TBL] [Abstract][Full Text] [Related]
9. Compatibility of aztreonam in four commercial peritoneal dialysis fluids.
Tobudic S; Prager I; Kussmann M; Obermüller M; Ursli M; Zeitlinger M; Wiesholzer M; Burgmann H; Poeppl W; Reznicek G
Sci Rep; 2020 Feb; 10(1):1788. PubMed ID: 32019947
[TBL] [Abstract][Full Text] [Related]
10. Pharmacodynamics of antimicrobials for the empirical treatment of nosocomial pneumonia: a report from the OPTAMA Program.
Sun HK; Kuti JL; Nicolau DP
Crit Care Med; 2005 Oct; 33(10):2222-7. PubMed ID: 16215374
[TBL] [Abstract][Full Text] [Related]
11. Pharmacodynamic profiling of commonly prescribed antimicrobial drugs against Escherichia coli isolates from urinary tract.
Cuba GT; Pignatari AC; Patekoski KS; Luchesi LJ; Kiffer CR
Braz J Infect Dis; 2014; 18(5):512-7. PubMed ID: 24731938
[TBL] [Abstract][Full Text] [Related]
12. [In vitro emergence of ertapenem resistance in Escherichia coli producing extended-spectrum β-lactamase].
Villar HE; Jugo MB; Visser M; Hidalgo M; Hidalgo G; Maccallini GC
Rev Esp Quimioter; 2014 Mar; 27(1):51-5. PubMed ID: 24676243
[TBL] [Abstract][Full Text] [Related]
13. Impact of erythrocytes on bacterial growth and antimicrobial activity of selected antibiotics.
Nussbaumer-Pröll AK; Knotzer S; Eberl S; Reiter B; Stimpfl T; Jäger W; Poschner S; Zeitlinger M
Eur J Clin Microbiol Infect Dis; 2019 Mar; 38(3):485-495. PubMed ID: 30687870
[TBL] [Abstract][Full Text] [Related]
14. Compatibility of ciprofloxacin with commercial peritoneal dialysis solutions.
Kussmann M; Ferth A; Obermüller M; Pichler P; Zeitlinger M; Wiesholzer M; Burgmann H; Poeppl W; Reznicek G
Sci Rep; 2019 Apr; 9(1):6512. PubMed ID: 31019280
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial spectrum of activity for meropenem and nine broad spectrum antimicrobials: report from the MYSTIC Program (2002) in North America.
Rhomberg PR; Jones RN;
Diagn Microbiol Infect Dis; 2003 Sep; 47(1):365-72. PubMed ID: 12967752
[TBL] [Abstract][Full Text] [Related]
16. [Investigation of the susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. strains to ertapenem and other carbapenems].
Kuzucu C; Yetkin F; Görgeç S; Ersoy Y
Mikrobiyol Bul; 2011 Jan; 45(1):28-35. PubMed ID: 21341156
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of ertapenem and other carbapenems against extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae clinical isolates in a tertiary care center in Turkey.
Kiremitci A; Dinleyici EC; Erben N; Durmaz G; Yargic ZA; Aybey AD; Usluer G
Expert Opin Pharmacother; 2008 Jun; 9(9):1441-9. PubMed ID: 18518776
[TBL] [Abstract][Full Text] [Related]
18. In vitro antibacterial activities of antibiotics against Pseudomonas aeruginosa in peritoneal dialysis fluid.
Shalit I; Welch DF; San Joaquin VH; Marks MI
Antimicrob Agents Chemother; 1985 Jun; 27(6):908-11. PubMed ID: 3927837
[TBL] [Abstract][Full Text] [Related]
19.
Goodlet KJ; Nicolau DP; Nailor MD
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923865
[TBL] [Abstract][Full Text] [Related]
20. Antibiotic stability in commercial peritoneal dialysis solutions: influence of formulation, storage and duration.
Roberts DM; Fernando G; Singer RF; Kennedy KJ; Lawrence M; Talaulikar G
Nephrol Dial Transplant; 2011 Oct; 26(10):3344-9. PubMed ID: 21324977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
